SCHOTT Pharma AG & Co. KGaA, DE000A3ENQ51

SCHOTT Pharma AG & Co. KGaA / DE000A3ENQ51

26.02.2024 - 15:52:54

SCHOTT Pharma AG & Co. KGaA: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements

EQS Preliminary announcement financial reports: SCHOTT Pharma AG & Co. KGaA / Preliminary announcement on the disclosure of financial statements
SCHOTT Pharma AG & Co. KGaA: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements

26.02.2024 / 15:52 CET/CEST
Preliminary announcement of the publication of quarterly reports and quarterly/interim statements transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

SCHOTT Pharma AG & Co. KGaA hereby announces that the following financial reports shall be disclosed:

Report Type: Quarterly/ Interim statement within the 1st half-year

Language: German
Date of disclosure: February 29, 2024
Address: https://www.schott-pharma.com/investor-relations/de/news-und-veroeffentlichungen/berichte-und-praesentationen/

Language: English
Date of disclosure: February 29, 2024
Address: https://www.schott-pharma.com/investor-relations/news-publications/reports-and-presentations/

Report Type: Quarterly/ Interim statement within the 2nd half-year

Language: German
Date of disclosure: August 29, 2024
Address: https://www.schott-pharma.com/investor-relations/de/news-und-veroeffentlichungen/berichte-und-praesentationen/

Language: English
Date of disclosure: August 29, 2024
Address: https://www.schott-pharma.com/investor-relations/news-publications/reports-and-presentations/

26.02.2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com